gene_symbol
SLAMF7
hgnc_id
HGNC:21394
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Elotuzumab binds SLAMF7 on tumor cells; its Fc engages FcγRIIIa on NK cells to trigger NK cell–mediated ADCC, with additional NK activation via SLAMF7 signaling, leading to lysis of SLAMF7+ cells.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Also known as CS1/CD319/CRACC; expressed on myeloma cells and NK cells
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06152575
disease_id_num_tar_ref
61
drug_id_num_tar_ref
148